Anesthesia

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida

Retrieved on: 
Wednesday, April 3, 2024
Johns Hopkins Hospital, MLSS, Anesthesia, Risk, Trauma, MD, ESI, CPT, ASC, Injection, Safety, Spine, Pain management, Pain, Physician, Epidural steroid injection, Nursing

ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into PRC Alliance Pain Relief Center at Ormond Beach, Florida. PRC Alliance Pain Relief Centers operates 7offices and an ambulatory surgical center (ASC) located across Central Florida, with 15 providers. PRC Alliance Pain Relief Centers is a family of pain management specialists who are dedicated to relieving pain through exceptional and compassionate care.

Key Points: 
  • ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables into PRC Alliance Pain Relief Center at Ormond Beach, Florida.
  • PRC Alliance Pain Relief Centers operates 7offices and an ambulatory surgical center (ASC) located across Central Florida, with 15 providers.
  • PRC Alliance Pain Relief Centers is a family of pain management specialists who are dedicated to relieving pain through exceptional and compassionate care.
  • Adoption of the technology follows a successful evaluation by Dr. Sanjay Bakshi, MD, a pain management physician and CEO of PRC Alliance Pain Relief Centers in Ormond Beach, Florida.

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Retrieved on: 
Tuesday, March 26, 2024
Diabetes, Disease, Echocardiography, HSCS, Congress, Algorithm, Intelligence, Anesthesia, Patient, Mortality, LVDD, Society, Anesthesiology, Type, Use, American Society of Echocardiography, Medical device

Preoperative left ventricular diastolic dysfunction (LVDD) is very common and one of the important causes of perioperative morbidity and mortality in cardiac and non-cardiac surgeries.

Key Points: 
  • Preoperative left ventricular diastolic dysfunction (LVDD) is very common and one of the important causes of perioperative morbidity and mortality in cardiac and non-cardiac surgeries.
  • In the study, patients undergoing preoperative anesthesia evaluation for cardiac and non-cardiac surgeries were enrolled.
  • For patients indicated for preoperative echocardiography, LVDD was diagnosed and graded as per American Society of Echocardiography (ASE) guidelines and a MyoVista wavECG was also performed.
  • Based on these findings, 25 of the 60 non-LVDD patients could be safely excluded from referral to preoperative echocardiography.

Recent Research Supports Sedation-Free TNE for Effective Management of GI Disorders Utilizing the EvoEndo System

Retrieved on: 
Wednesday, April 3, 2024
Health, Medical Devices, Hospitals, Health Technology, Other Health, General Health, Biotechnology, Safety, Anesthesia, TNE, Evaluation, Patient, Pediatrics, Efficacy, Abstract, Male, Workflow, EGD, Eosinophilic esophagitis, Endoscopy, Esophagogastroduodenoscopy, Nursing

Recently published scientific abstracts and peer-reviewed papers support the efficacy and demand for gastroenterology programs to offer Sedation-Free Transnasal Endoscopy (TNE) utilizing the EvoEndo System as an alternative to traditional TNE.

Key Points: 
  • Recently published scientific abstracts and peer-reviewed papers support the efficacy and demand for gastroenterology programs to offer Sedation-Free Transnasal Endoscopy (TNE) utilizing the EvoEndo System as an alternative to traditional TNE.
  • Findings suggest a valuable opportunity to optimize the patient experience, minimize risks associated with anesthesia, and improve diagnostic outcomes.
  • There were no adverse events, suggesting promising potential for TNE as a diagnostic tool in assessing esophageal disorders.
  • These studies highlight the advantages of offering unsedated TNE and the viability of broader applications in pediatric endoscopy.

GE HealthCare and Hartford HealthCare Renew and Evolve 7-Year Collaboration to Advance Patient Care and Access in Connecticut

Retrieved on: 
Thursday, March 14, 2024
Technology, Hospitals, Health Technology, Other Health, Radiology, Health, Pharmaceutical, Data Management, Artificial Intelligence, Diagnosis, Deep learning, PET/CT, Head, Experiential learning, Algorithm, Longevity, MRI, X-ray, HHC, Anesthesia, OEC, Patient, Artificial intelligence, Acquisition, Mammography, Software, Critical care, GE HealthCare, Artifact, Multimedia, Nuclear medicine

The Care Alliance strives to assist Hartford HealthCare in increasing access to innovation while decreasing the total cost of care for patients.

Key Points: 
  • The Care Alliance strives to assist Hartford HealthCare in increasing access to innovation while decreasing the total cost of care for patients.
  • The collaboration will increase patients’ access to GE HealthCare’s most current imaging technology, and may provide shorter scan times, reduced waiting times for care, and enable clinicians to have greater accuracy in diagnostic assessments.
  • The agreement also includes GE HealthCare patient monitoring, anesthesia, maternal infant care and diagnostic cardiology technologies.
  • GE HealthCare and Hartford HealthCare will also execute build-in-place upgrades with some existing MRI, CT, PET/CT, and X-rays to refresh older systems with fewer construction costs and while minimizing waste, equipment downtime, and disruption to patient care.

Non-dispersive Infrared (NDIR) Market worth $965 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 2, 2024
Carbon, Condensate, Gas, Temperature, Health, PLC, Transport, Isoflurane, HVAC, Sevoflurane, Lidar, Oxygen, Honeywell, OTDR, Capnography, SCADA, Row, Anesthesia, Controller, Security alarm, Desflurane, Air pollution, Region, Oil, Thermography, Environmental monitoring, Textile, COVID-19, MSA, Digital, VOC, Yokogawa Electric, Amphenol, Carbon dioxide, Brownfield land, Nitrous oxide, Natural gas, Carbon monoxide, Mining, Acoustic, Environment, Optical fiber, Volatile organic compound, Plastic, Atmosphere, Water, Power, Hardware

Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.

Key Points: 
  • Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.
  • Monitoring of refrigerant gases, capnography etc are likely to boost NDIR market.
  • NDIR market for VOCs to hold high market share during the forecast period.
  • Industrial & Manufacturing segment by vertical in NDIR industry to hold high market share during the forecast period.

Non-dispersive Infrared (NDIR) Market worth $965 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 2, 2024
Carbon, Condensate, Gas, Temperature, Health, PLC, Transport, Isoflurane, HVAC, Sevoflurane, Lidar, Oxygen, Honeywell, OTDR, Capnography, SCADA, Row, Anesthesia, Controller, Security alarm, Desflurane, Air pollution, Region, Oil, Thermography, Environmental monitoring, Textile, COVID-19, MSA, Digital, VOC, Yokogawa Electric, Amphenol, Carbon dioxide, Brownfield land, Nitrous oxide, Natural gas, Carbon monoxide, Mining, Acoustic, Environment, Optical fiber, Volatile organic compound, Plastic, Atmosphere, Water, Power, Hardware

Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.

Key Points: 
  • Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.
  • Monitoring of refrigerant gases, capnography etc are likely to boost NDIR market.
  • NDIR market for VOCs to hold high market share during the forecast period.
  • Industrial & Manufacturing segment by vertical in NDIR industry to hold high market share during the forecast period.

Implant Placement in the Posterior Mandible is important to avoid injury to the IAN

Retrieved on: 
Friday, March 29, 2024
IAN, Eating, Dental implant, Dentistry, Dysesthesia, Anesthesia, Anatomy, DDS, OMFS, FACP, Journal, Mandible, MBA, Paresthesia, Drinking, Inferior alveolar nerve, Jaw, DMD, Health

LAWRENCE, Kan., March 29, 2024 /PRNewswire-PRWeb/ -- Journal of Oral Implantology – As dentistry advances, gaining a deeper understanding of the oral cavity's anatomy and the role of each nerve and bone is paramount. One area that continues to revolutionize is implantology. While dental implants can provide an elevated level of patient care, the placement of the implant carries many inherent risks that clinicians must consider before performing the procedure. A primary focus during an implant procedure is to avoid vital structures of the jaw, including the inferior alveolar nerve (IAN). The IAN is a sensory nerve found in the mandible and, if disturbed, can result in short-term or permanent paresthesia, anesthesia, or dysesthesia.

Key Points: 
  • In a recent study, published in the Journal of Oral Implantology, researchers evaluate dental implant placement in the posterior mandible to avoid injury to the inferior alveolar nerve.
  • A primary focus during an implant procedure is to avoid vital structures of the jaw, including the inferior alveolar nerve (IAN).
  • The IAN is a sensory nerve found in the mandible and, if disturbed, can result in short-term or permanent paresthesia, anesthesia, or dysesthesia.
  • The IAN is a sensory nerve found in the mandible and, if disturbed, can result in short-term or permanent paresthesia, anesthesia, or dysesthesia.

Ambulatory Management Solutions Rebrands to Ambulatory Anesthesia Care (AAC)

Retrieved on: 
Tuesday, March 26, 2024
Health, Anesthesia, EMR, Patient, Accreditation, Acquisition, Credentialing, MD, Quality of life, MBA, Anesthetic, MSO, AMS, Patient safety, CMO, Marketing, Pacific Northwest, AAC, Nursing

CHICAGO, March 26, 2024 /PRNewswire/ -- Ambulatory Anesthesia Care—formerly Ambulatory Management Solutions—began in 2007 when Chicago's Mobile Anesthesiologists, a pioneer of office-based anesthesia in operation since 1996, brought business services in-house.

Key Points: 
  • CHICAGO, March 26, 2024 /PRNewswire/ -- Ambulatory Anesthesia Care—formerly Ambulatory Management Solutions—began in 2007 when Chicago's Mobile Anesthesiologists , a pioneer of office-based anesthesia in operation since 1996, brought business services in-house.
  • AMS, now AAC, has continued to grow and help its practice partners set a new national standard in office-based anesthesia and perioperative services.
  • CEO Scott Mayer noted, "AAC has a unique approach to both ambulatory anesthesia, and healthcare.
  • Dr. Marlon Michel, MBA, founder, M2 Anesthesia , continued, "M2 Anesthesia has been delivering anesthetics to the Pacific Northwest's pediatric dental patients since 2009.

AANA and AANA Insurance Services Announce 2024 Rm8 iNoV8 Pitch Competition

Retrieved on: 
Wednesday, March 20, 2024
Congress, Anesthesia, Volvo, Patient, Public, Private sector, Anesthesiology, Patient safety, Multimedia, Certified Registered Nurse Anesthetist, Nursing

ROSEMONT, Ill., March 20, 2024 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) and AANA Insurance Services will host the inaugural Rm8 iNoV8 Pitch Competition on August 5, at the AANA 2024 Annual Congress in San Diego, California.

Key Points: 
  • ROSEMONT, Ill., March 20, 2024 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) and AANA Insurance Services will host the inaugural Rm8 iNoV8 Pitch Competition on August 5, at the AANA 2024 Annual Congress in San Diego, California.
  • The Rm8 iNoV8 Pitch Competition is open to CRNA-led innovations across sectors, including academia, healthcare, community, public health, or the private sector.
  • "The Rm8 iNoV8 Pitch Competition advances AANA's commitment to driving innovation and progress for CRNAs, their patients and the anesthesiology profession," said AANA CEO Bill Bruce.
  • "It gives five entrepreneurial teams the opportunity to pitch their products to potential customers and investors, network with industry professionals, receive pitch coaching, and enhance their brand with inclusion in marketing efforts by AANA, AANA Insurance Services, and Rm8."

Methodist Le Bonheur Healthcare first in Tennessee to offer "paradigm-shifting" technology for AFib patients

Retrieved on: 
Thursday, March 14, 2024
MLH, Le Bonheur Children's Hospital, Heat, Atrial fibrillation, Anesthesia, Patient, Methodist University Hospital, PFA, Medtronic, Freezing, Arrhythmia, Ventricular fibrillation, Methodism, Cardiac electrophysiology, Hospital

MEMPHIS, Tenn. , March 14, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare is proud to announce it is the first healthcare system in Tennessee to offer the Medtronic PulseSelect™ Pulsed Field Ablation (PFA) technology to patients suffering from atrial fibrillation (AF).

Key Points: 
  • MEMPHIS, Tenn. , March 14, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare is proud to announce it is the first healthcare system in Tennessee to offer the Medtronic PulseSelect™ Pulsed Field Ablation (PFA) technology to patients suffering from atrial fibrillation (AF).
  • "Pulsed Field Ablation is a paradigm-shifting technology," said Dr. Yehoshua Levine, division chief of cardiac electrophysiology at Methodist Le Bonheur Healthcare who performed the first PFA at Methodist University Hospital.
  • "PFA allows us to deliver timely treatment to more patients when they need help the most," said Dr. James Litzow, cardiac electrophysiologist with Methodist Le Bonheur Germantown Hospital.
  • Across the MLH system , the cardiovascular team at Methodist University Hospital conducted the first PFA for the healthcare system on March 11 with Methodist Le Bonheur Germantown Hospital's cardiovascular team conducting its first PFA on March 12.